100
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Association Analysis about HLA-DRB1, -DQB1 Polymorphism and Auto-Antibodies Against α1-Adrenergic Receptors in Chinese Patients with Essential Hypertension

, , , &
Pages 532-539 | Received 17 Nov 2009, Accepted 23 Jan 2010, Published online: 23 Nov 2010

REFERENCES

  • Jahns R, Boivin V, Siegmund C, Inselmann G, Lohse MJ, Boege F. Autoantibodies activating human β1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 1999;99:649–654.
  • Liao YH, Wei YM, Wang M, Wang ZH, Yuan HT, Cheng LX.. Autoantibodies against AT1-receptor and alpha1-adrenergic receptors in patients with hypertension. Hypertens Res 2002; 25:641–646.
  • Herse F, Verlohren S, Wenzel K, Pape J, Muller DN, Modrow S, Wallukat G, Luft FC, Redman CW, Dechend R. Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study. Hypertension 2009; 53:393–398.
  • Fu ML, Herlitz H, Schulze W, Wallukat G, Micke P, Eftekhari P, Sjögren KG, Hjalmarson A, Müller-Esterl W, Hoebeke J. Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J Hypertension 2000; 18:945–953.
  • Fu ML, Herlitz H, Wallukat G, Hilme E, Hedner T, Hoebeke J, Hjalmarson A. Functional autoimmune epitope on 1-adrenergic receptors in patients with malignant hypertension. Lancet 1994;344:1660–1663.
  • Luther HP, Homuth V, Wallukat G. α 1-adrenergic receptor antibodies in patients with primary hypertension. Hypertension 1997; 29:678–682.
  • Wenzel K, Haase H, Wallukat G, Derer W, Bartel S, Homuth V, Herse F, Hubner N, Schulz H, Janczikowski M, Lindschau C, Schroeder C, Verlohren S, Morano I, Muller DN, Luft FC, Dietz R, Dechend R, Karczewski P. Potential relevance of α1-adrenergic receptor autoantibodies in refractory hypertension. PLoS One 2008;3:e3742.
  • Bkaily G, El-Bizri N, Bui M, Sukarieh R, Jacques D, Fu ML. Modulation of intracellular Ca2++ via L-type calcium channels in heart cells by the autoantibody directed against the second extracellular loop of the alpha1-adrenoceptors. Can J Physiol Pharmacol 2003;81: 234–246.
  • Fu ML, Wallukat G, Hjalmarson A, Hoebeke, J. Characterization of anti-peptide antibodies directed against an extracellular immunogenic epitope on the human a1-adrenergic receptor. Clin Exp Immunol 1994;97:146–151.
  • Yan L, Xu Y, Yao H, Xue W, Tian J, Ren H, Wu Y, Yang G, Ma XL, Liu H. The effects of autoantibodies against the second extracellular loop of α1-adrenoceptor on vasoconstriction. Basic Res Cardiol 2009;104:581–589.
  • Zhou ZH, Liao YH, Wei YM, Wei F, Wang B, Li LD, Wang M, Liu K. Cardiac remodeling after long-term stimulation by antibodies against the a1-adrenergic receptor in rats. Clin Immunol 2005;114:164–173.
  • Okruhlicova L, Morwinski R, Schulze W, Bartel S, Weismann P, Tribulova N, Wallukat G. Autoantibodies against G-protein-coupled receptors modulate heart mast cells. Cell Mol Immunol 2007;4:127–133.
  • Dzielak D. The immune system and hypertension. Hypertension 1992;19:136–144 (suppl I).
  • Fu ML. Do immune system changes have a role in hypertension. J Hypertens 1995;13: 1259–1265.
  • Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok CC, French M, Mallal S, Christiansen F. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999;167:257–274.
  • Ogata T, Gregoire L, Goddard KAB, Skunca M, Tromp G, Lancaster WD, Parrado AR, Lu Q, Shibamura H, Sakalihasan N, Limet R, MacKean GL, Arthur C, Sueda T, Kuivaniemi H Evidence for association between the HLA-DQA locus and abdominal aortic aneurysms in the Belgian population: a case control study. BMC Med Genet 2006;7:67–80.
  • Warrens A, Lechler R. HLA in Health and Disease. Elsevier: Academic Press, 1999.
  • Van Eden W. Immunoregulation of autoimmune diseases. Human Immunology 2006;67:446–453.
  • Trowsdale J, Powis SH. The MHC: Relationship between linkage and function. Curr Opin Genet Dev 1992;2:492–497.
  • Janeway CA, Travers P, Walport M, Schlomchik MJ. Immunobiology, 6th ed: The Immune System in Health and Disease. New York: Garland Publishing, 2005.
  • O'Hanlon TP, Rider LG, Mamyrova G, Targoff IN, Arnett FC, Reveille JD, Carrington M, Gao XJ, Oddis CV, Morel PA, Malley JD, Malley K, Shamim EA, Chanock SJ, Foster CB, Bunch T, Reed AM, Love LA, Miller FW. HLA polymorphisms in African Americans with idiopathic inflammatory myopathy. Arthritis Rheum 2006;54:3670–3681.
  • Liu W, Li WM, Sun NL. HLA-DQA1, -DQB1 polymorphism and genetic susceptibility to idiopathic dilated cardiomyopathy in Hans of Northern China. Ann Hum Genet 2005;69:382–388.
  • Fanning GC, Welsh KI, Bunn C, Dubois R, Black CM. HLA association in three mutually exclusive autoantibody subgrouos in UK systemic sclerosis patients. Br J Rheumatol 1998;37:201–207
  • Gerbase-DeLima M, DeLima JJ, Persoli LB, Silva HB, Marcondes M, Bellotti G. Essential hypertension and histocompatibility antigens. A linkage study. Hypertension 1989; 14:604–609.
  • Patel R, Johnson J. Histocompatibility antigens in black patients with essential hypertension. Circulation 1981;64: 1042–1044.
  • Luque OM, Martell CN, Llorente PL, Fernández PC, Fernández-Cruz A. Severe hypertension in the Spanish population. Association with specific HLA antigens. Hypertension 1983;5:149–152.
  • Gerbase-DeLima M, Ladalardo MA, DeLima JJ, Silva HB, Bellotti G, Pileggi F. Essential hypertension and histocompatibility antigens. An association study. Hypertension 1992; 19:400–402.
  • Titkov YS, Ziskina RA, Temirov AA, Gybladze DV, Bubnova LN. HLA antigens in borderline and essential hypertension. Am J Hypertens 1993;6:885–887.
  • Gerbase-DeLima M, Paiva RLF, Bortolotto LA, Bernardes-Silva H, De Lima JJG. Human leukocyte antigens and malignant essential hypertension. Am J Hypertens 1998;11:729–731.
  • Fields HA, Davis CL, Bradley DW, Mayanrd JE. Experimental conditions affecting the sensitivity of enzyme-linked immunosorbent assay (ELISA) for detection of hepatitis B surface antigen (HBsAg). Bull World Health Organ 1983;61:135–142.
  • Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific prmers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantion. Tissue Antigens 1992;39:225–235.
  • Bunce M, O'Neill CM, Barnardo MCNM, Krausa P, Browning MJ, Morris PJ, Welsh KI. Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 and DQB1 by PCR with 144 primer mixes utilising sequence-specific primers (PCR-SSP). Tissue Antigens 1995;46:355–367.
  • Olerup O, Aldener A, Fogdell A. HLA-DQB1 and DQA1 typing by PCR amplifications with sequence specific primers (PCR-SSP). Tissue Antigens 1993;41:119–134.
  • Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. BMJ 1995;310: 170.
  • Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphic loci. Cell Res 2005;15:97–98.
  • John DR, Abul KA. Paths to understanding the genetic basis of autoimmune disease. Nature 2005;435:584–589.
  • Pearce SH, Merriman TR. Genetic progress towards the molecular basis of autoimmunity. Trends Mol Med 2006;12: 90–98.
  • Ferrari I, Levin MJ, Wallukat G, Elies R, Lebesgue D, Chiale P, Elizari M, Rosenbaum M, Hoebeke J. Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor. J Exp Med 1995;182:59–65.
  • Stepan H, Wallukat G, Schultheiss HP, Faber R, Walther T. Is parvovirus B19 the cause for autoimmunity against the angiotensin II type receptor?? J Reprod Immunol 2007;73: 130–134.
  • LaMarca B, Wallukat G, Llinas M, Herse F, Dechend R, Granger JP. Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats. Hypertension 2008;52:1168–1172.
  • Andersson EC, Hansen BE, Jacobsen H, Madsen LS, Andersen CB, Engberg J, Rothbard JB, Sönderstrup-McDevitt G, Malmström V, Holmdahl R, Svejgaard A, Fugger L. Definition of MHC and T cell receptor contacts in the HLA-DR4 restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc Natl Acad Sci USA 1998;95:7574–7569.
  • Fugger L, Rothbard JB, McDevitt GS. Specificity of an HLADRB1**0401-restricted T cell response to type II collagen. Eur J Immunol 1996;26:923–933.
  • Jun KR, Choi SE, Cha CH, Oh HB, Heo YS, Ahn HY, Lee KJ. Meta-analysis of the association between HLA-DRB1 allele and rheumatoid arthritis susceptibility in Asian populations. J Korean Med Sci 2007;22:973–980.
  • Lin L, Chen Y, Xiao Z, Huang S, Yang Z. The association of HLA-DRB1 alleles with rheumatoid arthritis in the Chinese Shantou population: a follow-up study. Biochem Cell Biol 2007;85:227–238.
  • Kilpatrick DC, Liston WA, Gibson F, Livingstone J. Association between susceptibility to preeclampsia within families and HLA DR4. Lancet 1989;2:1063–1065.
  • Limas C, Limas CJ, Boudoulas H, Bair R, Graber H, Sparks L, Wooley CF. Anti-beta-receptor antibodies in familial cardiomyopathy: correlation with HLA-DR and HLA-DQ gene polymorphisms. Am Heart J 1994;127:382–386.
  • Takakuwa K, Honda K, Ishii K, Hataya I, Yasuda M, Tanaka K. Studies on the HLA-DRB1 genotypes in Japanese women with severe preeclampsia positive and negative for cardiolipin antibody using a polymerase chain reaction-restriction fragment length polymorphism method. Hum Reprod 1999;14: 2980–2986.
  • Limas CJ, Limas C. HLA-DR antigen linkage of anti-beta receptor antibodies in idiopathic dilated and ischaemic cardiomyopathy. Br Heart J 1992;67:402–405.
  • Ou D, Mitchell LA, Tingle AJ. HLA-DR restrictive supertypes dominate promiscuous T cell recognition: association of multiple HLA-DR molecules with susceptibility to autoimmune diseases. J Rheumatol 1997;24:253–261.
  • Cornelia MW, Jörg JG. Association of MHC and rheumatoid arthritis: HLA polymorphisms in phenotypic variants of rheumatoid arthritis. Arthritis Res 2000;2:212–216.
  • Jones EY, Fugger L, Strominger JL, Siebold C. MHC class II proteins and disease: A structural perspective. Nat Rev Immunol 2006;6:271–282.
  • Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 2002;53:79–91.
  • Jeffrey DW, Jonathan K P. Haplotype blocks and linkage disequilibrium in the human genome. Nature Reviews Genetics 2003;4:587–597.
  • Petrone A, Giorgi G, Mesturino CA, Capizzi M, Cascino I, Nistico L, Osborn J, Mario UD, Buzzetti R.. Association of DRB1**04-DQB1**0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population. THYROID 2001;11:171–175.
  • Hermann R. Turpeinen H, Laine AP, Veijola R, Knip M, Simell O, Sipilä I, Akerblom HK, Ilonen J. HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens 2003;62:162–169.
  • Yongsoo P, George S. Eisenbarth Genetic susceptibility factors of Type 1 diabetes in Asians. Diabetes Metab Res Rev 2001;17:2–11.
  • Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, Mychaleckyj JC, Todd JA, Bonella P, Fear AL, Lavant E, Louey A, Moonsamy P. Type 1 Diabetes Genetics Consortium, Type 1 Diabetes Genetics Consortium HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008;57:1084–1092.
  • Zanelli E, Huizinga TW, Guerne PA, Vischer TL, Tiercy JM, Verduyn W, Schreuder GM, Breedveld FC, de Vries RR. An extended HLA-DQ-DR haplotype rather than DRB1 alone contributes to RA predisposition. Immunogenetics 1998;48: 394–401.
  • Laivoranta-Nyman S, Mottonen T, Hermann R, Tuokko J, Luukkainen R, Hakala M, Hannonen P, Korpela M, Yli-Kerttula U, Toivanen A, Ilonen J. HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis. Ann Rheum Dis 2004;63:1406–1412.
  • Schork NJ. Genetically complex cardiovascular traits: origins, problems, and potential solutions. Hypertension 1997;29:145–149.
  • Vidan-Jeras B, Gregoric A, Jurca B, Jeras M, Bohinjec M. Possible influence of genes located on chromosome 6 within or near to the major histocompatibility complex on development of essential hypertension. Eur J Physiol 2000;439:60–62 (suppl).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.